Two Key Questions About Payer Strategies in 2021

PM360 asked experts in market access and working with payers what innovations to expect ...

What Trump’s Win Might Mean for Pharma

First, let’s acknowledge the obvious—nobody knows what Trump’s win might mean for the pharma ...